As a clinical consultant for the Breathright drug research firm, you are given the task of using an in vitro assay to screen ten thousand drug analogs to find the most potent beta-2 receptor agonist. When analyzing your data, the biomarker that you should screen for is:

Questions 263

ATI RN

ATI RN Test Bank

Lifespan Pharmacology Questions

Question 1 of 5

As a clinical consultant for the Breathright drug research firm, you are given the task of using an in vitro assay to screen ten thousand drug analogs to find the most potent beta-2 receptor agonist. When analyzing your data, the biomarker that you should screen for is:

Correct Answer: C

Rationale: In this scenario, the correct biomarker to screen for when evaluating the potency of beta-2 receptor agonists among ten thousand drug analogs using an in vitro assay is EC50, which stands for the half maximal effective concentration. EC50 represents the concentration of a drug needed to achieve 50% of its maximal effect. The reason why EC50 is the most appropriate biomarker in this context is that it provides a quantitative measure of the potency of a drug in eliciting a specific response, in this case, the activation of beta-2 receptors. By determining the EC50 values of different drug analogs, you can directly compare their potencies and select the most potent beta-2 receptor agonist for further development. Emax, on the other hand, refers to the maximal effect a drug can produce, which is not suitable for comparing the potencies of different drug analogs. Half-life is a pharmacokinetic parameter that represents the time taken for the concentration of a drug in the body to reduce by half, which is not relevant in this case. Understanding the concept of EC50 and its significance in pharmacology is crucial for drug development and screening processes. It allows researchers to identify the most potent compounds with the lowest effective concentrations, leading to more targeted and effective drug therapies. By mastering the interpretation of EC50 values, pharmacologists can make informed decisions in drug development and clinical practice.

Question 2 of 5

A29-year-old woman suffering from allergic rhinitis started treatment with loratadine. The drug can completely counteract the histamine-induced release of which of the following endogenous compounds?

Correct Answer: D

Rationale: In this scenario, the correct answer is D) Nitric oxide. Loratadine, as an antihistamine, works by blocking the action of histamine on certain cells in the body. Histamine is a compound released during allergic reactions and triggers various responses. One of these responses is the release of nitric oxide, which plays a role in inflammation and vasodilation. Option A) Pepsin is a digestive enzyme produced in the stomach and is not directly affected by antihistamines like loratadine. Option B) Gastric acid production is not directly inhibited by antihistamines like loratadine. Histamine does play a role in stimulating gastric acid secretion, but loratadine primarily targets histamine receptors involved in allergic responses. Option C) Cyclic adenosine monophosphate (cAMP) is a signaling molecule that can be influenced by histamine, but loratadine's primary mechanism of action is through histamine receptors rather than cAMP pathways. Educationally, understanding the interactions between drugs and endogenous compounds like histamine and nitric oxide is crucial in pharmacology. It highlights the specific targets and mechanisms of action of different medications, aiding in the selection of appropriate treatments for various conditions. This knowledge is essential for healthcare professionals to provide safe and effective care to patients.

Question 3 of 5

A 21-year-old woman suffering from seasonal allergic conjunctivitis started a treatment with eye drops of azelastine, a second-generation histamine H1 antagonist. Second-generation H1 antagonists are used locally in the conjunctiva instead of first-generation H1 antagonists to provide which of the following therapeutic advantages?

Correct Answer: A

Rationale: The correct answer is A) Negligible effects on pupil size and accommodation. Second-generation H1 antagonists like azelastine are preferred for local use in the conjunctiva over first-generation H1 antagonists due to their selective action on histamine receptors in the target tissue, which leads to reduced systemic side effects. Option B) Negligible penetration into the central nervous system is incorrect because second-generation H1 antagonists still have the potential to enter the systemic circulation and reach the central nervous system, albeit in lower amounts compared to first-generation drugs. Option C) Higher dilating activity on conjunctival vessels is incorrect as second-generation H1 antagonists are chosen for their lower affinity for blood vessels in the conjunctiva, leading to reduced risk of vascular dilation and subsequent redness. Option D) Higher blocking activity on lacrimal gland secretion is incorrect because second-generation H1 antagonists are not selected for their increased blocking activity on lacrimal gland secretion but rather for their reduced impact on pupil size and accommodation. In an educational context, understanding the differences between first and second-generation H1 antagonists is crucial for healthcare professionals to make informed decisions when prescribing medications for conditions like allergic conjunctivitis. Second-generation drugs offer a more targeted approach with fewer systemic side effects, making them a preferred choice for local treatment in sensitive areas like the eye.

Question 4 of 5

What is implied by 'active transport'?

Correct Answer: D

Rationale: Active transport refers to the movement of substances across a cell membrane against their concentration gradient, requiring energy expenditure in the form of ATP. This process allows the cell to accumulate substances against their concentration gradients to maintain cellular functions. Option A is incorrect because diffusion is a passive process, not an active transport mechanism that requires energy. Option B is incorrect because active transport does involve energy consumption. Option C describes endocytosis, a process where the cell engulfs material by wrapping cell membrane around it to form a vesicle, which is not the same as active transport. Understanding active transport is crucial in pharmacology as it explains how certain drugs can be transported into cells even when there is a higher concentration of the drug outside the cell. This knowledge is vital in designing drugs that can effectively target specific cells or organelles within the body. It also helps in understanding drug resistance mechanisms where cells may actively pump out drugs using active transport mechanisms.

Question 5 of 5

Biological barriers include all except

Correct Answer: A

Rationale: In the context of Lifespan Pharmacology, understanding biological barriers is crucial for comprehending drug absorption, distribution, and elimination in different stages of life. The correct answer, A) Renal tubules, is not a biological barrier. Renal tubules are part of the kidney responsible for the reabsorption and secretion of substances, not a barrier to drug passage. Cell membranes (Option B), capillary walls (Option C), and the placenta (Option D) are all examples of biological barriers that play significant roles in pharmacology. Cell membranes act as selective barriers controlling the movement of substances in and out of cells. Capillary walls form barriers between the bloodstream and surrounding tissues, influencing drug distribution. The placenta acts as a barrier between the maternal and fetal circulation, affecting drug transfer during pregnancy. Educationally, this question helps reinforce the importance of understanding biological barriers in pharmacology. By knowing which structures act as barriers to drug passage, healthcare professionals can make informed decisions regarding drug dosing, potential interactions, and drug safety in different patient populations. Understanding these concepts is essential for providing effective and safe pharmacological interventions across the lifespan.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions